Lower BCL11B expression is associated with adverse clinical outcome for patients with myelodysplastic syndrome-MedSci.cn

Lower BCL11B expression is associated with adverse clinical outcome for patients with myelodysplastic syndrome

Huang, X; Chen, CT; Zhong, MJ; Geng, SX; Zhao, YJ; Li, MM; Deng, CX; Zeng, LJ; Wu, P; Lu, ZS; Weng, JY; Du, X; Li, YQ

Weng, JY; Du, X (corresponding author), Guangdong Acad Med Sci, Guangdong Prov Peoples Hosp, Dept Hematol, Guangzhou 510080, Peoples R China.; Li, YQ (corresponding author), Jinan Univ, Inst Hematol, Minist Educ, Key Lab Regenerat Med, Guangzhou 510632, Peoples R China.

Abstract

Myelodysplastic syndrome (MDS) is an aggressive and genetically heterogeneous disease with poor prognosis. Cellular immune disorder is a common charac......

Full Text Link

Links

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

Lower BCL11B expression is associated with adverse clinical outcome for patients with myelodysplastic syndrome

科室

工具

服务